Health Canada authorizes a clinical trial for the UM171 molecule
Health Canada has officially given the green light for the first phase of clinical trials involving transplantation of cord blood cells expanded with the small molecule UM171 for the treatment of blood-related cancers. Thanks to our collaborators at IRIC and Hôpital Maisonneuve-Rosemont